1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Reborn Coffee received a Nasdaq notice on September 16, 2026, saying it no longer meets the minimum $2,500,000 stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported stockholders' equity of $735,642 in its June 30, 2026 Form 10-Q, and it must submit a plan to regain compliance by November 2, 2026. The notice has no immediate effect on the listing, but the company states there is no assurance its plan will be accepted, and a rejected plan could lead to an appeal to a Nasdaq Hearings Panel.
On September 16, 2026, Nasdaq notified the company that its reported stockholders' equity of $735,642 is below the $2,500,000 minimum under Listing Rule 5550(b)(1).
The company also does not meet Nasdaq's alternative standards for market value of listed securities or net income from continuing operations.
A plan to regain compliance is due by November 2, 2026; if accepted, Nasdaq can grant up to 180 calendar days to regain compliance.
A separate Nasdaq notice about the late June 30, 2026 Form 10-Q was closed on September 16, 2026, after the company filed the report on September 14, 2026.
Idaho Copper received a U.S. Forest Service letter approving its Exploration Plan of Operations and 2026 annual operating plan for the CuMo project in Boise County, Idaho, clearing the way for drilling and road-building. The company says the approval removes the remaining administrative conditions and lets it start work, with up to 15,000 feet of diamond core drilling targeted this season.
Forest Service letter approving the Exploration Plan of Operations and 2026 annual operating plan; USFS accepted the company's reclamation surety bond on or before the letter date
USFS accepted the signed Forest Service Evaluation form on September 9, 2026
Company is targeting up to 15,000 feet of additional diamond core drilling this season, with a larger campaign planned for 2027 toward a Prefeasibility Study
Compass Therapeutics said the FDA recommended it conduct a trial demonstrating a survival benefit before submitting a Biologics License Application for tovecimig in previously treated advanced biliary tract cancer. The company said it does not believe a new trial is warranted before submission and will keep engaging with the FDA, which means the timing and path to approval are now uncertain.
FDA recommended a trial demonstrating a survival benefit before a BLA submission for tovecimig
Phase 2/3 COMPANION-002 showed ORR of 18.0% vs. 5.3% with paclitaxel alone (p=0.0228)
Median progression-free survival was 4.7 vs. 2.6 months, hazard ratio 0.44 (p<0.0001)
Overall survival analyses did not reach statistical significance due to crossover
The FDA has lifted the full clinical hold on Filana Therapeutics' IND for a planned Phase 2a study of simufilam in TSC-related epilepsy. Patient screening is expected to begin by the first quarter of 2027, so the hold removal is a development milestone rather than a change in financial results.
FDA lifted the full clinical hold on the simufilam IND, announced September 22, 2026
Planned Phase 2a study: 16-week randomized, double-blind trial at 13 U.S. sites, targeting 40 subjects aged 12 to 55
Patient screening expected to begin by the first quarter of 2027
Company completed trial-readiness work during the hold, including engaging a clinical research organization and identifying sites
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.